肢端肥大症多模式治疗后糖尿病与高血压的持续存在
该回顾性研究纳入522例按预定方案治疗的肢端肥大症患者,按末次就诊时疾病活动状态分为5组。诊断时糖尿病和高血压患病率分别为30%和37%,末次就诊时为30.6%和38%,均高于一般人群。手术缓解组末次就诊时糖尿病患病率低于疾病持续活动组(25% vs 40%,P=0.01)。
要点
- 诊断时糖尿病和高血压患病率分别为30%和37%,末次就诊时分别为30.6%和38%,均高于一般人群。
- 手术缓解组末次就诊时糖尿病患病率低于疾病持续活动组(25% vs 40%,P=0.01)。
- 多因素分析显示糖尿病与诊断时IGF-1>2倍正常上限、肢端肥大症持续活动、末次就诊时高血压、大腺瘤及女性相关。
核心结论
- 研究结果强调管理这些患者时需采取整体方法,不仅关注GH和IGF-1水平的控制,还应关注每种合并症的及时诊断和特异性治疗。
研究设计与样本
- 回顾性研究,在三级医疗中心开展,共纳入522例按预定方案治疗的肢端肥大症患者。
主要发现
- 队列按末次就诊时疾病活动状态分层:手术缓解组n=122、药物控制组n=92、疾病活动组n=148、IGF-1不一致组n=64、GH不一致组n=96。
- 诊断时糖尿病和高血压患病率分别为30%和37%,末次就诊时分别为30.6%和38%。
- 两种合并症在诊断时和末次就诊时的患病率均高于一般人群。
- 手术缓解组末次就诊时糖尿病患病率低于疾病持续活动组(25% vs 40%,P=0.01)。
- 多因素分析中,糖尿病与诊断时IGF-1>2倍正常上限、肢端肥大症持续活动、末次就诊时高血压、大腺瘤及女性相关。
关键数值与推荐
- 手术缓解组末次就诊时糖尿病患病率25% vs 疾病持续活动组40%(P=0.01)。
- 诊断时糖尿病患病率30%、高血压患病率37%;末次就诊时分别为30.6%和38%。
临床怎么用
- 作者认为,管理肢端肥大症患者应采取整体方法,不仅关注GH和IGF-1水平控制,还应关注每种合并症的及时诊断和特异性治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Diabetes and hypertension are frequent comorbidities of acromegaly. OBJECTIVE: To analyze the course of diabetes and hypertension at diagnosis and after multimodal therapy in a large cohort of patients with acromegaly. DESIGN AND SETTING: Retrospective study at a tertiary care center. PATIENTS AND METHODS: A total of 522 patients with acromegaly treated according to a preestablished protocol. MAIN OUTCOME MEASURES: Prevalence of diabetes and hypertension and its relationship with biochemical indices of acromegalic control. RESULTS: The cohort was stratified according to disease activity upon last visit to clinic: (1) surgical remission (n = 122), (2) pharmacologically controlled (n = 92), (3) active disease (n = 148), (4) insulinlike growth factor (IGF)-1 discordance (n = 64), and (5) growth hormone (GH) discordance (n = 96). The prevalence of diabetes and hypertension at diagnosis was 30% and 37%, respectively, and did not change upon the last visit (30.6% and 38%). Both comorbidities were more prevalent at diagnosis and on the last visit than in the general population. Diabetes was less prevalent on the last visit in patients who achieved surgical remission than in those who persisted with active disease (25% vs 40%, P = 0.01). Upon multivariate analysis, diabetes was associated with an IGF-1 at diagnosis >2× upper limit of normal, with the persistence of active acromegaly, the presence of hypertension upon the last visit, with the presence of a macroadenoma, and with female sex. CONCLUSION: Our findings underscore the importance of an integral approach when managing these patients, focusing not only on the control of GH and IGF-1 levels but also on the timely diagnosis and the specific treatment of each comorbidity.
引用
- González B, Vargas G, de Los Monteros ALE, et al. Persistence of Diabetes and Hypertension After Multimodal Treatment of Acromegaly. J Clin Endocrinol Metab. 2018. PMID: 29618021. doi:10.1210/jc.2018-00325
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。